Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Beachler

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Diabetes Care|February 16, 2024
Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort StudyMary S Anthony, Vanita R Aroda, Lauren E Parlett, et al.
The Journal of Infectious Diseases|May 9, 2015
High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV InfectionDaniel C Beachler, Yingshi Guo, Wiehong Xiao, et al.
Menopause (New York, N.Y.)|July 14, 2023
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort studySarah R Hoffman, Samuel Governor, Kimberly Daniels, et al.
Pharmacoepidemiology and Drug Safety|October 23, 2021
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data"Daniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2021
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims dataDaniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Oral Oncology|November 21, 2016
Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continentsGypsyamber D'Souza, Devasena Anantharaman, Tarik Gheit, et al.
Lancet (London, England)|June 12, 2022
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databasesHui-Lee Wong, Mao Hu, Cindy Ke Zhou, et al.
Oral Oncology|January 4, 2017
Corrigendum to 'Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents' [Oral Oncol. 62 (2016) 20-27]Gypsyamber D'Souza, Devasena Anantharaman, Tarik Gheit, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2025
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United StatesPatricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.
International Journal of Cancer|January 22, 2017
Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancerDevasena Anantharaman, Behnoush Abedi-Ardekani, Daniel C Beachler, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Diabetes Care|February 16, 2024
Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort StudyMary S Anthony, Vanita R Aroda, Lauren E Parlett, et al.
The Journal of Infectious Diseases|May 9, 2015
High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV InfectionDaniel C Beachler, Yingshi Guo, Wiehong Xiao, et al.
Menopause (New York, N.Y.)|July 14, 2023
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort studySarah R Hoffman, Samuel Governor, Kimberly Daniels, et al.
Pharmacoepidemiology and Drug Safety|October 23, 2021
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data"Daniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2021
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims dataDaniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Oral Oncology|November 21, 2016
Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continentsGypsyamber D'Souza, Devasena Anantharaman, Tarik Gheit, et al.
Lancet (London, England)|June 12, 2022
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databasesHui-Lee Wong, Mao Hu, Cindy Ke Zhou, et al.
Oral Oncology|January 4, 2017
Corrigendum to 'Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents' [Oral Oncol. 62 (2016) 20-27]Gypsyamber D'Souza, Devasena Anantharaman, Tarik Gheit, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2025
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United StatesPatricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.
International Journal of Cancer|January 22, 2017
Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancerDevasena Anantharaman, Behnoush Abedi-Ardekani, Daniel C Beachler, et al.
Pageof 6